PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.
0.90
Current Ratio 0.5–0.75x Medical - Pharmaceuticals median of 1.35. Guy Spier would worry about potential short-term pinch.
0.36
Quick Ratio below 0.5x Medical - Pharmaceuticals median of 0.77. Jim Chanos might see a liquidity gap if the firm cannot tap more credit swiftly.
0.28
Cash Ratio near Medical - Pharmaceuticals median of 0.28. Charlie Munger would see it as typical for the sector’s operating style.
38.17
Interest coverage of 38.17 versus zero Medical - Pharmaceuticals median. Walter Schloss would verify if our debt service capacity provides advantages.
-0.98
Negative short-term coverage while Medical - Pharmaceuticals median is 0.00. Seth Klarman would scrutinize cash flow quality and look for immediate refinancing solutions.